GPT and cancer: Negative regulators of ALT include the ATRX/DAXX histone chaperone complex and the histone variant H3.3, which are often mutated in ALT-positive cancers (Heaphy et al. 2011; Kannan et al. 2012; Minasi et al. 2021; Schwartzentruber et al. 2012).